Hosted on MSN1mon
FDA Expands Approval of Esketamine for DepressionThe FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants, maker Johnson ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback